Condition: Older Adults (65 Years and Older) · Medical Patients in the Emergency Department · Sponsor: Herlev Hospital
The goal of this clinical trial is to learn about the effect of zinc supplementation once daily for 12 months in older acute medical patients. The main question it aims to answer is: • Can daily zinc supplementation for 12 months increase Days Alive and Out of Hospital (DAOH)? Researchers will compare zinc supplementation to a control group, a group who do not receive zinc supplementation, to see if zinc supplementation can increase Days Alive and Out of Hospital, reduce antibiotic use, readmissions and mortality. Participants will take 22 mg zinc supplementation once daily for 12 months or not. The researchers will draw data on readmissions, antibiotic use and mortality during the 12 months follow-up period.
This description comes directly from the study's public registry record.
Cecilia M Lund, Senior consultant, PhD · +45 38686112 · cecilia.margareta.lund@regionh.dk
Pernille H Ellegaard, MD, PhD student · +45 38681616 · pernille.holm.ellegaard.01@regionh.dk
Always discuss trial participation with your own doctor first.
| Department of Medicine | Herlev, Copenhagen, Denmark | Recruiting |
| Department of Medicine, Copenhagen University Hospital - Herlev and Gentofte | Herlev, Denmark | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07367412